Who owns Biotelemetry?

Tip: Access positions for across all investors

Analyze quarterly positions in Biotelemetry with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Biotelemetry stock

Who bought or sold Biotelemetry this quarter?

There are no current stakeholders of Biotelemetry.

This is normal when the security:

  • Has been acquired or taken private
  • Has merged with another entity
  • Has changed its name and has a new CUSIP (and/or symbol)
  • Has been delisted and the ticker has changed

Please use Search to find the security you were looking for.

Who sold out of Biotelemetry?

Fund or Company Name Date Sold Shares Held Valued At
Goldman Sachs Group Dec 2020 209k $15M
Jpmorgan Chase & Co Dec 2020 97k $7.0M
Front Row Advisors Dec 2020 29k $2.1M
Tealwood Asset Management Dec 2020 24k $1.7M
Citigroup Dec 2020 18k $1.3M
Equitec Proprietary Markets Dec 2020 16k $1.2M
Virtu Financial Dec 2020 7.9k $568k
Logan Capital Management Mar 2021 1.6k $116k